What Artiva Biotherapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 22 |
| Sells | 16 | 22 |
| Total trades | 24 | 67 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 320,735 | 12,570,941 |
| Disposed | 300,943 | 378,993 |
| Net activity | +19,792 | +12,191,948 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Banerjee Subhashis | Chief Medical Officer | Nov 02 | Sale for tax withholding · S | −1,110 | $4.18 | −$4.64K | 168,738 |
| Bush Jennifer | COO, CLO, Compliance Officer | Nov 02 | Sale for tax withholding · S | −8,439 | $4.18 | −$35.3K | 357,720 |
| Aslan Fred | Chief Executive Officer | Nov 02 | Sale for tax withholding · S | −62,178 | $4.18 | −$260K | 1,457,428 |
| Horan Christopher | Chief Tech Operations Officer | Nov 02 | Sale for tax withholding · S | −10,423 | $4.18 | −$43.6K | 302,321 |
| Aslan Fred | Chief Executive Officer | Oct 06 | Open-market sale · S | −23,463 | $7.20 | −$169K | 1,519,606 |
| Aslan Fred | Chief Executive Officer | Oct 05 | Sale for tax withholding · S | −61,696 | $6.84 | −$422K | 1,543,069 |
| Horan Christopher | Chief Tech Operations Officer | Oct 05 | Sale for tax withholding · S | −10,340 | $6.84 | −$70.7K | 312,744 |
| Banerjee Subhashis | Chief Medical Officer | Oct 05 | Sale for tax withholding · S | −1,099 | $6.84 | −$7.51K | 169,848 |
| Bush Jennifer | COO, CLO, Compliance Officer | Oct 05 | Sale for tax withholding · S | −8,370 | $6.84 | −$57.2K | 366,159 |
| Aslan Fred | Chief Executive Officer | Sep 15 | Grant / award · A | +110,000 | — | — | 1,604,765 |
| Aslan Fred | Chief Executive Officer | Sep 10 | Grant / award · A | +45,000 | — | — | 1,494,765 |
| Banerjee Subhashis | Chief Medical Officer | Sep 09 | Grant / award · A | +30,000 | — | — | 170,947 |
| Bush Jennifer | COO, CLO, Compliance Officer | Sep 09 | Grant / award · A | +45,000 | — | — | 374,529 |
| Horan Christopher | Chief Tech Operations Officer | Sep 09 | Grant / award · A | +40,000 | — | — | 323,084 |
| Miralles Gines Diego | President & Head of R&D | Sep 09 | Grant / award · A | +45,000 | — | — | 122,500 |
| Aslan Fred | Chief Executive Officer | Sep 08 | Open-market sale · S | −23,429 | $10.92 | −$256K | 1,449,765 |
| Aslan Fred | Chief Executive Officer | Sep 03 | Sale for tax withholding · S | −61,888 | $11.16 | −$690K | 1,473,194 |
| Bush Jennifer | COO, CLO, Compliance Officer | Sep 03 | Sale for tax withholding · S | −8,391 | $11.16 | −$93.6K | 329,529 |
| Horan Christopher | Chief Tech Operations Officer | Sep 03 | Sale for tax withholding · S | −10,366 | $11.16 | −$116K | 283,084 |
| Banerjee Subhashis | Chief Medical Officer | Sep 03 | Sale for tax withholding · S | −1,100 | $11.16 | −$12.3K | 140,947 |
Loading...